Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Acute administration of buprenorphine in humans: partial agonist and blockade effects.

Walsh SL, Preston KL, Bigelow GE, Stitzer ML.

J Pharmacol Exp Ther. 1995 Jul;274(1):361-72.

PMID:
7542336
2.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
3.

Assessment of buprenorphine in a drug discrimination procedure in humans.

Bigelow GE, Preston KL.

NIDA Res Monogr. 1992;121:28-37. Review.

PMID:
1406908
4.

Buprenorphine: considerations for pain management.

Johnson RE, Fudala PJ, Payne R.

J Pain Symptom Manage. 2005 Mar;29(3):297-326. Review.

PMID:
15781180
5.

Buprenorphine.

Lewis JW.

Drug Alcohol Depend. 1985 Feb;14(3-4):363-72. Review.

PMID:
2986930
6.

New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.

Soyka M.

Subst Abuse Rehabil. 2015 Jan 6;6:1-14. doi: 10.2147/SAR.S45585. eCollection 2015. Review.

8.

[Pharmacology of buprenorphine].

Arnould JF, Pinaud M.

Ann Fr Anesth Reanim. 1991;10(6):559-64. Review. French. No abstract available.

PMID:
1664666
9.

[Actions and side effects of methadone].

Jage J.

Dtsch Med Wochenschr. 1990 Apr 6;115(14):552-5. Review. German. No abstract available.

PMID:
2182319
10.

Use and misuse of opioid agonists in opioid addiction.

Modesto-Lowe V, Swiezbin K, Chaplin M, Hoefer G.

Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091. Review.

Supplemental Content

Support Center